Corporate social responsibility of pharmaceutical industry in Korea
Background: Global pharmaceutical companies in Korea argue that the development of innovative drugs should be recognized as a social contribution, yet it has been countered by various stakeholders. The need to distinguish between philanthropic activities and Corporate Social Responsibility (CSR) of...
Saved in:
Main Authors: | Green Bae (Author), Jeong-Hoon Ahn (Author), Kyung-Min Lim (Author), SeungJin Bae (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How Sensitive is Sensitivity Analysis?: Evaluation of Pharmacoeconomic Submissions in Korea
by: SeungJin Bae, et al.
Published: (2022) -
Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea
by: Inseon Choi, et al.
Published: (2020) -
How can we improve patients' access to new drugs under uncertainties? : South Korea's experience with risk sharing arrangements
by: Boram Lee, et al.
Published: (2021) -
Workers' Exposure to Indium Compounds at the Electronics Industry in Republic of Korea
by: Gwangyong Yi, et al.
Published: (2021) -
Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
by: Sax S, et al.
Published: (2009)